IL17A and juvenile idiopathic arthritis: Based on the studies showing the role of IL-17 in the pathogenesis of JIA and the role of the “IL-23/IL-17” axis, clinical studies were initially conducted to evaluate the effect of IL-23 inhibitors in the treatment of this disease [67].